Target intelligence / Profile preview

ST6GAL2 intronic transcript 1 (ST6GAL2-IT1)

Target
ST6GAL2-IT1
Molecular classification
Other (non-coding RNA)
01

Overview

ST6GAL2 intronic transcript 1 is a long non-coding RNA (lncRNA) derived from the intronic region of the ST6GAL2 gene. As of now, there is little to no peer-reviewed evidence of its functional role in biological processes, disease association, or involvement as a therapeutic target. It is not classified as an enzyme, receptor, transporter, or canonical therapeutic target. The main ST6GAL2 gene encodes the enzyme ST6 beta-galactoside alpha-2,6-sialyltransferase 2, which is involved in sialyltransferase activity, specifically transferring sialic acid to galactose on oligosaccharides. However, ST6GAL2-IT1 is a distinct transcript located within the intronic region of this protein-coding gene. There are no data indicating ST6GAL2-IT1 is a protein-coding gene or involved as a direct drug target, nor is there evidence of its role as a biomarker, therapeutic mechanism, or safety concern. Its naming and annotation suggest it is a non-coding transcript, and no canonical function or disease association can be assigned at this time. This is likely not a protein, receptor, enzyme, or standard biological target. The entry appears to be more descriptive of a location (an intronic non-coding RNA) rather than a molecular drug target.

Other names
ST6GAL2-IT1ST6GAL2 intronic transcript 1
02

Biological functions

Other (No well-characterized biological function)
03

Disease associations

Other (No established role in disease)

Beyond the preview

Go deeper on ST6GAL2 intronic transcript 1 (ST6GAL2-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ST6GAL2 intronic transcript 1 (ST6GAL2-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call